To learn more about our free trial prescription program, please call 1-844-668-6732 to speak with a NovoSecure™ Specialist.a
WE'RE HERE TO HELP
We understand that you might have concerns about costs and other aspects of your hemophilia B treatment. We're here to help eligible patients with product support through NovoSecure™.
We understand that you might have concerns about costs and other aspects of your hemophilia B treatment. We're here to help eligible patients with product support through NovoSecure™.

Image is for illustrative purposes only.

TRIAL PRESCRIPTION PROGRAM

aPatients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product for an FDA-approved indication, and who have commercial insurance or who are uninsured, may be eligible to receive a limited supply of free product. Patients who participate in any government, state, or federally funded medical or prescription benefit program, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to receive product support. Product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.
ADDITIONAL PRODUCT SUPPORT


-
Co-pay Assistance Program
Get help with co-pay costs for Rebinyn®.b
-
Patient Assistance Program
Apply for the Patient Assistance Program by downloading and completing the form, or call 1-844-668-6732 for more information.
bNovo Nordisk Hemophilia and Rare Bleeding Disorders Copay/Coinsurance Terms and Conditions: Enrolled patients are eligible for up to $12,000 in co-pay/coinsurance assistance per calendar year for each NNI hemophilia or rare bleeding disorder product. Assistance is retroactive to 60 days. Patients must be commercially insured and may not be participating in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance. Uninsured, cash-paying patients are not eligible to participate. Patients are eligible to receive co-pay/coinsurance assistance on an annual basis (12 months). Offer good only in the USA, Puerto Rico, Guam, Saipan, and Virgin Islands with participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA-approved indication.

RESOURCES FOR YOU
These materials can help you stay educated on bleeding disorders.


HAVE A QUESTION FOR US?
Hemophilia Community Liaisons are a great source of information.

